DocCheck AG

XTRA:AJ91 Rapport sur les actions

Capitalisation boursière : €41.4m

DocCheck Gestion

Gestion contrôle des critères 4/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Frank Antwerpes

Directeur général

€244.7k

Rémunération totale

Pourcentage du salaire du PDG75.5%
Durée du mandat du directeur généralno data
Propriété du PDG55.7%
Durée moyenne d'occupation des postes de direction5.3yrs
Durée moyenne du mandat des membres du conseil d'administration25.8yrs

Mises à jour récentes de la gestion

What Can We Conclude About DocCheck's (ETR:AJ91) CEO Pay?

Dec 07
What Can We Conclude About DocCheck's (ETR:AJ91) CEO Pay?

Recent updates

DocCheck's (ETR:AJ91) Returns On Capital Not Reflecting Well On The Business

Nov 19
DocCheck's (ETR:AJ91) Returns On Capital Not Reflecting Well On The Business

We Think You Can Look Beyond DocCheck's (ETR:AJ91) Lackluster Earnings

Apr 19
We Think You Can Look Beyond DocCheck's (ETR:AJ91) Lackluster Earnings

DocCheck (ETR:AJ91) Has Some Way To Go To Become A Multi-Bagger

Aug 04
DocCheck (ETR:AJ91) Has Some Way To Go To Become A Multi-Bagger

Estimating The Fair Value Of DocCheck AG (ETR:AJ91)

May 20
Estimating The Fair Value Of DocCheck AG (ETR:AJ91)

The Trend Of High Returns At DocCheck (ETR:AJ91) Has Us Very Interested

Nov 06
The Trend Of High Returns At DocCheck (ETR:AJ91) Has Us Very Interested

Returns On Capital Are A Standout For DocCheck (ETR:AJ91)

Mar 03
Returns On Capital Are A Standout For DocCheck (ETR:AJ91)

If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late

Jan 18
If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late

Do DocCheck's (ETR:AJ91) Earnings Warrant Your Attention?

Aug 26
Do DocCheck's (ETR:AJ91) Earnings Warrant Your Attention?

Should DocCheck AG (ETR:AJ91) Be Part Of Your Dividend Portfolio?

May 02
Should DocCheck AG (ETR:AJ91) Be Part Of Your Dividend Portfolio?

Investors Shouldn't Overlook DocCheck's (ETR:AJ91) Impressive Returns On Capital

Apr 18
Investors Shouldn't Overlook DocCheck's (ETR:AJ91) Impressive Returns On Capital

Should You Be Adding DocCheck (ETR:AJ91) To Your Watchlist Today?

Mar 23
Should You Be Adding DocCheck (ETR:AJ91) To Your Watchlist Today?

Is DocCheck AG's (ETR:AJ91) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Mar 04
Is DocCheck AG's (ETR:AJ91) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Did You Participate In Any Of DocCheck's (ETR:AJ91) Incredible 419% Return?

Feb 14
Did You Participate In Any Of DocCheck's (ETR:AJ91) Incredible 419% Return?

Could The DocCheck AG (ETR:AJ91) Ownership Structure Tell Us Something Useful?

Jan 27
Could The DocCheck AG (ETR:AJ91) Ownership Structure Tell Us Something Useful?

Under The Bonnet, DocCheck's (ETR:AJ91) Returns Look Impressive

Jan 10
Under The Bonnet, DocCheck's (ETR:AJ91) Returns Look Impressive

If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late

Dec 22
If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late

What Can We Conclude About DocCheck's (ETR:AJ91) CEO Pay?

Dec 07
What Can We Conclude About DocCheck's (ETR:AJ91) CEO Pay?

DocCheck AG's (ETR:AJ91) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Nov 22
DocCheck AG's (ETR:AJ91) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Analyse de la rémunération des PDG

Comment la rémunération de Frank Antwerpes a-t-elle évolué par rapport aux bénéfices de DocCheck?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jun 30 2024n/an/a

€2m

Mar 31 2024n/an/a

€2m

Dec 31 2023€245k€185k

€2m

Sep 30 2023n/an/a

€4m

Jun 30 2023n/an/a

€6m

Mar 31 2023n/an/a

€6m

Dec 31 2022€250k€190k

€6m

Sep 30 2022n/an/a

€7m

Jun 30 2022n/an/a

€7m

Mar 31 2022n/an/a

€9m

Dec 31 2021€250k€190k

€11m

Sep 30 2021n/an/a

€12m

Jun 30 2021n/an/a

€13m

Mar 31 2021n/an/a

€11m

Dec 31 2020€211k€151k

€9m

Sep 30 2020n/an/a

€7m

Jun 30 2020n/an/a

€4m

Mar 31 2020n/an/a

€4m

Dec 31 2019€245k€185k

€3m

Sep 30 2019n/an/a

€3m

Jun 30 2019n/an/a

€3m

Mar 31 2019n/an/a

€3m

Dec 31 2018€244k€184k

€2m

Sep 30 2018n/an/a

€2m

Jun 30 2018n/an/a

€2m

Mar 31 2018n/an/a

€2m

Dec 31 2017€237k€177k

€2m

Rémunération vs marché: La rémunération totale de Frank ($USD 256.39K ) est inférieure à la moyenne des entreprises de taille similaire sur le marché German ($USD 472.15K ).

Rémunération et revenus: La rémunération de Frank a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.

PDG

Frank Antwerpes

no data

Titularisation

€244,721

Compensation

Dr. Frank Nicolas Antwerpes serves as the Chief Executive Officer at DocCheck Guano AG. He served as the Chief Executive Officer of DocCheck Medizinbedarf und Logistik GmbH. Dr. Antwerpes serves as Preside...

Équipe de direction

NomPositionTitularisationCompensationPropriété
Frank Antwerpes
President of the Management Board & CEOno data€244.72k55.71%
€ 23.0m
Philip Stadtmann
CFO & Member of Management Board5.3yrs€232.41kpas de données
Thilo Kolzer
COO & Member of Management Board5.3yrs€234.81kpas de données
Jens Knoop
CTO & Member of Management Board5.3yrs€195.80kpas de données

5.3yrs

Durée moyenne de l'emploi

Gestion expérimentée: L'équipe dirigeante de AJ91 est chevronnée et expérimentée (5.3 années d'ancienneté moyenne).

Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Joachim Pietzko
Chairman of the Supervisory Board25.8yrs€19.20kpas de données
Winfried Leimeister
Deputy Chairwoman of the Supervisory Board25.8yrs€9.60kpas de données
Karin Immenroth
Chief Data & Analytics Officer and Member of Supervisory Board2.5yrs€9.60kpas de données

25.8yrs

Durée moyenne de l'emploi

Conseil d'administration expérimenté: Le conseil d'administration de la AJ91 est chevronné et expérimenté ( 25.8 années d'ancienneté moyenne).